Crohn's Disease MRI: Bowel Imaging

Crohn's disease is a chronic inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract, from mouth to anus, but most commonly involves the small bowel (ileum) and colon. It affects around 115,000 people in the UK. MRI — particularly MR enterography (MRE) — has become an essential tool for diagnosing, monitoring, and managing Crohn's disease because it shows bowel wall inflammation, complications, and disease extent without radiation, making it ideal for repeat imaging in a condition that often requires lifelong monitoring.

If you have been experiencing persistent abdominal pain, diarrhoea, weight loss, or fatigue, or if you have known Crohn's disease and need to check for disease activity or complications, an MRI of the small bowel or abdomen gives your gastroenterologist detailed information about what is happening inside your gut.

Understanding Crohn's Disease

Crohn's disease is an autoimmune condition that causes patches of inflammation anywhere in the GI tract (unlike ulcerative colitis, which only affects the large bowel). Inflammation can extend through the full thickness of the bowel wall, leading to complications that MRI is particularly good at detecting.

Key Features

• Skip lesions — patches of inflammation separated by normal bowel. Unlike ulcerative colitis, which is continuous.
• Transmural inflammation — affects the full thickness of the bowel wall, not just the surface.
• Complications — strictures (narrowing), fistulae (abnormal tunnels between organs or to the skin surface), and abscesses (collections of pus). MRI detects all of these.
• Perianal disease — fistulae and abscesses around the anus, affecting up to 30% of Crohn's patients. Pelvic MRI is the gold standard for assessing perianal Crohn's disease.

Symptoms

• Chronic or relapsing abdominal pain (often right lower abdomen)
• Diarrhoea (sometimes bloody)
• Weight loss and poor appetite
• Fatigue
• Fever during flares
• Mouth ulcers
• Perianal symptoms — pain, discharge, abscesses
• Extra-intestinal manifestations — joint pain, skin rashes (erythema nodosum, pyoderma gangrenosum), eye inflammation

MR Enterography (MRE) — The Key Scan

MR enterography is a specialised MRI protocol designed to assess the small bowel in detail. It has largely replaced small bowel barium follow-through and CT enterography for Crohn's assessment because it offers equivalent or better accuracy without radiation — critical for young patients who will need repeated imaging over their lifetime.

What MRE Shows

• Active inflammation — thickened, enhancing bowel wall (normal small bowel wall is 1-3mm; inflamed segments can be 5-10mm or more). Mucosal enhancement, wall oedema (bright on T2), and surrounding mesenteric inflammation ("comb sign" — engorged vasa recta) all indicate active disease.
• Strictures — narrowed segments of bowel. MRI helps distinguish between inflammatory strictures (which may respond to medication) and fibrotic strictures (which usually need surgery or balloon dilatation). Inflammatory strictures show wall oedema and enhancement; fibrotic strictures show wall thickening without significant enhancement.
• Fistulae — abnormal connections between bowel loops (entero-enteric), bowel and bladder (enterovesical), bowel and skin (enterocutaneous), or bowel and vagina (rectovaginal). MRI shows the fistula track as a bright line on T2-weighted images with contrast enhancement.
• Abscesses — walled-off collections of fluid/pus. Appear as rim-enhancing fluid collections. May need drainage.
• Disease extent and distribution — MRE maps which segments of bowel are affected and their length. This guides treatment decisions.
• Perianal disease — pelvic MRI using the St James's classification shows fistula complexity and guides surgical planning.

MRI Scoring Systems

Radiologists may use standardised scoring systems to quantify disease activity:

• MaRIA (Magnetic Resonance Index of Activity) — scores wall thickness, oedema, ulceration, and enhancement. Correlates well with endoscopic activity.
• London score — a simpler scoring system used in clinical practice.
• Clermont score — for diffusion-weighted imaging assessment of activity.

What to Expect During an MR Enterography

An MRE takes 35-50 minutes and requires more preparation than a standard MRI:

Preparation

• Oral contrast (bowel preparation) — you will drink approximately 1-1.5 litres of a non-absorbable oral contrast agent (usually mannitol, sorbitol, or polyethylene glycol solution) over 45-60 minutes before the scan. This distends the small bowel, making it possible to assess wall thickness and abnormalities. The liquid is not pleasant but not painful — it tastes slightly sweet and may cause mild bloating.
• Fasting — typically fast for 4-6 hours before the scan.
• Antispasmodic — Buscopan (hyoscine butylbromide) or glucagon injection is given just before scanning to reduce bowel movement and improve image quality.
• IV contrast — gadolinium is injected through a cannula. Kidney function (eGFR) may need to be checked beforehand.

During the Scan

You lie on your back or front (varies by centre). Breath-holds of 15-20 seconds are required for some sequences. The scan includes T2-weighted, diffusion-weighted, and post-contrast T1-weighted sequences.

What MRI Cannot Show

• Mucosal detail — MRI cannot see the fine mucosal surface of the bowel the way endoscopy can. Small, flat ulcers or very early mucosal inflammation may be missed. Colonoscopy with biopsy remains the gold standard for diagnosing and grading mucosal disease in the colon and terminal ileum.
• Histological diagnosis — MRI cannot provide a tissue diagnosis. Biopsy (via endoscopy) is needed to confirm Crohn's disease and distinguish it from other conditions.
• Large bowel in detail — MRE is optimised for the small bowel. While the colon is visible, colonoscopy is better for colonic assessment.

Alternative Diagnostic Approaches

• Colonoscopy with ileoscopy — the gold standard for diagnosing Crohn's disease in the large bowel and terminal ileum. Allows direct visualisation and biopsy. Cannot assess the rest of the small bowel.
• CT enterography (CTE) — similar information to MRE but uses radiation. Reserved for acute presentations or when MRI is not available.
• Capsule endoscopy — a swallowed camera capsule that images the entire small bowel. Good for detecting mucosal disease that MRE may miss. Contraindicated if a stricture is suspected (the capsule can get stuck).
• Ultrasound — bowel ultrasound in experienced hands can detect wall thickening and complications. Increasingly used for monitoring in Crohn's disease due to convenience and cost. Less accurate than MRE for mapping disease extent.
• Blood tests and biomarkers — CRP, ESR, full blood count (anaemia, raised platelets), albumin (nutrition), faecal calprotectin (the most useful non-invasive marker of gut inflammation). A normal faecal calprotectin makes active Crohn's disease very unlikely.

Treatment Pathways

• Inducing remission — corticosteroids (prednisolone, budesonide) for acute flares. Exclusive enteral nutrition (liquid diet) in children and sometimes adults.
• Maintaining remission — immunomodulators (azathioprine, mercaptopurine, methotrexate). Biologic therapies (infliximab, adalimumab, vedolizumab, ustekinumab) for moderate-to-severe disease or disease not responding to immunomodulators.
• Surgery — around 50% of Crohn's patients will need at least one operation within 10 years of diagnosis. Common operations: resection of strictured or fistulating segments, stricturoplasty (widening a narrowed segment without removing it), drainage of abscesses, and management of perianal fistulae (seton insertion, fistula plug, LIFT procedure).
• Monitoring — regular MRE or ultrasound to assess disease activity, treatment response, and detect complications before they become emergencies. NICE recommends MRI for monitoring small bowel Crohn's to minimise radiation exposure.

UK Statistics

• Around 115,000 people in the UK have Crohn's disease
• Peak age of diagnosis: 15-30 years
• UK incidence: approximately 10 per 100,000 per year (one of the highest in the world)
• Around 50% of patients require surgery within 10 years of diagnosis
• Crohn's disease costs the NHS an estimated £720 million annually
• The UK has seen a steady increase in Crohn's incidence over the past 50 years

Frequently Asked Questions

Related Articles

• Fatty Liver Disease MRI
• MRI Scan for Kidney Problems
• Can an MRI Detect Cancer?